Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Remimazolam Tosilate is a new short-acting benzodiazepines used in sedation. It has the
advantages of rapid metabolism, quick recovery without injection pain. This study aims to
compared with Midazolam, study whether Remimazolam Tosilate can achieve the same sedation
effect with lower side effects on sedation maintenance period, During the recovery period of
anesthesia, can Remimazolam Tosilatebe more stable and rapid.